Welcome to KAHR Medical
The mission at KAHR Medical is to develop novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
The company's drug development pipeline is built around 'signal converter proteins (SCP)' - a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. Read More... |
  Animated clip: SCP technology in autoimmune |
|
|
News & Events
Sanofi and Hadasit Bio-Holdings invest in KAHR Medical (View the Press Release)
|
